{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:31:26Z","timestamp":1773052286613,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.04.019","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T19:31:45Z","timestamp":1586979105000},"page":"349-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-135X","authenticated-orcid":false,"given":"Erkan","family":"Cure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-6459","authenticated-orcid":false,"given":"Medine","family":"Cumhur Cure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.04.019_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/VHRM.S1905","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.dsx.2020.04.019_bib2","first-page":"E14","article-title":"An update on the tissue renin angiotensin system and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.dsx.2020.04.019_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","article-title":"Angiotensin-(1-7), adipokines and inflammation","volume":"95","author":"Lelis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2020.04.019_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000002481","article-title":"Comment on \u2018Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","author":"Cure","year":"2020","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.dsx.2020.04.019_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25848","article-title":"Comment on \"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","author":"Cure","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.dsx.2020.04.019_bib6","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1073\/pnas.84.21.7663","article-title":"Intracellular pH in human and experimental hypertension","volume":"84","author":"Resnick","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dsx.2020.04.019_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2013.08.043","article-title":"The regulation of NHE\u2081 and NHE\u2083 activity by angiotensin II is mediated by the activation of the angiotensin II type I receptor\/phospholipase C\/calcium\/calmodulin pathway in distal nephron cells","volume":"721","author":"Costa-Pessoa","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dsx.2020.04.019_bib8","doi-asserted-by":"crossref","DOI":"10.1159\/000507786","article-title":"Comment on \u2019should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade","author":"Cure","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.dsx.2020.04.019_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.dsx.2020.04.019_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.resp.2017.10.003","article-title":"Angiotensin 1-7 in the rostro-ventrolateral medulla increases blood pressure and splanchnic sympathetic nerve activity in anesthetized rats","volume":"247","author":"Bilodeau","year":"2018","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.dsx.2020.04.019_bib11","unstructured":"Mohammed A. Al-Dhahir, Joe M Das, Sandeep Sharma. Neurogenic pulmonary edema copyright \u00a9 2020, StatPearls Publishing LLC."}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:13:55Z","timestamp":1761729235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120300850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120300850"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.019","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}